NABI-HB HEPATITIS B IG 5ML SDV
- Manufacturer: BIOTEST PHARMACEUTICALS
- NDC #: 59730-4203-01
- Size: 5 ML / 1 VL
- NDC Drug Form: SOLUTION
- SKU: IMM420301
- NDC Strength: 1
- NDC Drug Route: INTRAMUSCULAR INJECTION
- NDC Name: NABI-HB
Nabi-HB® Hepatitis B Immune Globulin (Human) 5 mL Single Dose Vial - Solvent/Detergent Treated and Filtered
Nabi-HB, Hepatitis B Immune Globulin (Human), is indicated for treatment of acute exposure to blood containing HBsAg, perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg-positive persons and household exposure to persons with acute HBV infection in the following settings:
- Acute Exposure to Blood Containing HBsAg
Following either parenteral exposure (needlestick, bite, sharps), direct mucous membrane contact (accidental splash), or oral ingestion (pipetting accident), involving HBsAg-positive materials such as blood, plasma, or serum.
- Perinatal Exposure of Infants Born to HBsAg-positive Mothers
Infants born to mothers positive for HBsAg with or without HBeAg12.
- Sexual Exposure to HBsAg-positive Persons
Sexual partners of HBsAg-positive persons.
- Household Exposure to Persons with Acute HBV Infection
Infants less than 12 months old whose mother or primary caregiver is positive for HBsAg. Other household contacts with an identifiable blood exposure to the index patient.
Nabi-HB is indicated for intramuscular use only.
Verified Inventory Program-Consignment
This is an eligible product for the Verified Inventory Program-Consignment (VIPc™).
To add this item to your list of VIPc products, contact your FFF Sales Representative.
To learn more and/or get started with the program, click here or call (800) 843-7477 ext. 1142